Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized single-blind study of low-dose AS03-adjuvanted influenza vaccine versus Fluarix in adults
2006-003769-15Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of AS03-adjuvanted low-dose influenza vaccine and Fluarix in influenza (3 arms), sponsored by GSK. Primary endpoints: Serum haemagglutination-inhibition antibody titre, Humoral immune response at day 21 and 1 more. Started Aug 2006; status: completed.
02
Drugs
AS03-adjuvanted low-dose influenza vaccineFluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-003769-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003769-15.